{"abstract": "Valeant Pharmaceuticals says it will acquire PharmaSwiss, a maker of generic drugs, for 350 million euros.", "web_url": "https://dealbook.nytimes.com/2011/02/01/valeant-to-buy-pharmaswiss-for-481-million/", "snippet": "Valeant Pharmaceuticals says it will acquire PharmaSwiss, a maker of generic drugs, for 350 million euros.", "lead_paragraph": "Valeant Pharmaceuticals said on Tuesday that it would acquire PharmaSwiss, the maker of generic drugs, for 350 million euros ($481 million). ", "source": "The New York Times", "multimedia": [], "headline": {"main": "Valeant to Buy PharmaSwiss for $481 Million", "kicker": "DealBook", "content_kicker": null, "print_headline": "", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "organizations", "value": "AMGEN INC", "rank": 3, "major": "N"}, {"name": "organizations", "value": "Pfizer Inc", "rank": 4, "major": "N"}], "pub_date": "2011-02-01T12:10:46+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "byline": {"original": "By Chris V. Nicholson", "person": [{"firstname": "Chris", "middlename": "V.", "lastname": "Nicholson", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "", "_id": "nyt://article/6baca220-a65a-524a-8faa-f8f4e63c371b", "word_count": 161, "uri": "nyt://article/6baca220-a65a-524a-8faa-f8f4e63c371b"}